髓寡细胞糖蛋白抗体相关疾病 (MOGAD):诊断和管理的实用建议
Elia Sechi1, Matteo Gastaldi2, Rosa Cortese3
1Neurology Unit, University Hospital of Sassari, Sassari, Italy.
Journal of neuroimmunology
|October 30, 2025
概括
髓寡细胞糖蛋白抗体相关疾病 (MOGAD) 是一种独特的自身免疫性疾病. 早期诊断依赖于特定的临床和MRI发现,以及MOG抗体检测,指导治疗策略.
科学领域:
- 神经免疫学 神经免疫学
- 神经学 神经学
- 自身免疫性疾病 自身免疫性疾病
背景情况:
- 髓寡干细胞糖蛋白抗体相关疾病 (MOGAD) 是一种影响中枢神经系统的自身免疫性疾病.
- 它呈现出各种不同的临床症状和成像发现,与其他脱髓化疾病重叠.
- 最近的诊断标准有助于区分MOGAD.
研究的目的:
- 审查MOGAD的关键特征,重点关注临床和成像特征.
- 概述目前MOGAD的诊断方法.
- 为MOGAD管理提供实际建议.
主要方法:
- 审查最近的国际MOGAD小组提出的诊断标准.
- 在儿科和成人群体中对临床和MRI表型的分析.
- 目前治疗策略的总结,包括急性和慢性治疗.
主要成果:
- 诊断MOGAD需要通过基于细胞的测定在血清/CSF中的MOG抗体,加上兼容的临床MRI表型.
- 复发率在40-80%之间,疾病的进展不可预测.
- 治疗包括类固醇,血交换和潜在的IVIg用于急性管理;慢性治疗用于复发病例.
结论:
- MOGAD是一种独特的抗体介导的中枢神经系统疾病,表现不同.
- 准确的诊断取决于血清学MOG抗体检测和特征性的临床MRI发现.
- 有效的管理涉及根据疾病过程量身定制的急性和慢性治疗策略.
关键词:
MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG MOG莫加德 - 莫加德骨髓类寡腺细胞糖蛋白是一种骨髓类寡腺细胞蛋白.更多相关视频
08:03Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
Published on: April 15, 2014
83.8K
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
16.7K
相关概念视频
Myasthenia Gravis: Diagnostic Tests
1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K
Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
